Pr. Gilles Guillemin,
Head of the Neuroinflammation group – co-Director of the MND and Neurodegenerative diseases Research Centre. Australian School of Advanced Medicine (ASAM), Macquarie University, Sydney, Australie
Titre : Tryptophan metabolism and Neuroinflammation.
Date : Jeudi 15 janvier 2015 à 12h00.
Lieu : Salle des séminaires de l’Institut Jacques Monod, Bâtiment Buffon, 15 rue Hélène Brion, Aile B – RdC bas 18B, Université Paris Diderot, campus PRG.
Invité par : Bernard Portha
Professor Gilles Guillemin (the Macquarie Motor Neurone Disease Research Centre) is internationally recognised as a leader in the fields of tryptophan, neuroinflammation and neurotoxicity research. Gilles is currently leading a team of 12 researchers studying the involvement of tryptophan (an essential amino acid) in MND such as amyotrophic lateral sclerosis and Spinal muscular atrophy. Gilles has a large network of national and international collaborations. This work has opened numerous promising research opportunities. Gilles’ team is now mostly focusing on identifying and developing new therapeutic targets for these neuroinflammatory diseases.
